More than 1800 drug-induced deaths in 2020: report
30 May, 2022In 2020, drug-induced deaths were nearly twice as frequent among males as females, according to a new report by the National Drug and Alcohol Research Centre.
Dry eye: 77% Australians experience symptoms but many unaware
25 May, 2022Despite the discomfort, only 11% of people would see an optometrist and only around 3% would speak to a pharmacist for advice.
248K medicinal cannabis scripts approved
10 May, 2022Around 248,000 medicinal cannabis scripts have been approved in Australia since 2016, and the drug is increasingly prescribed for various conditions, reveals a new study.
New opioids standard encourages alternatives, cessation plans
28 April, 2022The Australian Commission on Safety and Quality in Health Care has launched a new national standard for opioid analgesics to help prevent long-term harm.
New drug study hopes to help kids with severe epilepsy
10 February, 2022Researchers from the University of South Australia are working with European researchers to investigate a range of FDA-approved drugs with an aim to help kids with severe epilepsy.
New medicines agreements a boost for supply, sustainability: SHPA
08 September, 2021The SHPA has welcomed the medicines agreements as vital to protecting patients against shortages and ensuring medicines are accessible, available and cost-efficient.
New standard for opioid analgesics
01 September, 2021The Australian Commission on Safety and Quality in Health Care is seeking comments on the draft clinical care standard for opioid analgesics.
Opioid overuse: Australia needs national strategy
04 August, 2021Australia needs a comprehensive, coordinated approach to overdose prevention by national and state governments and professional groups.
Infant pain-monitoring device gains international approval
28 May, 2021The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.
Last chance for aged-care providers to claim free PainChek licence
20 May, 2021This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.
Tech restores lives of those in chronic pain
19 May, 2021The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.
NSAIDs and pharmacists vital in low back pain management
28 April, 2021Patients with low back pain have been shown to respond well to NSAIDs such as ibuprofen, according to researchers at RMIT University.
Device blocks the pain of shots
14 April, 2021ShotBlocker is a non-invasive solution that has been shown to reduce or remove pain in 93.2% of users at half the cost of topical freezing sprays and anaesthetic creams.
FreshLeaf reveals medicinal cannabis report
13 April, 2021The product, pricing and patient analysis found that, over the last six months, intense medicinal cannabis product competition has kept downward pressure on prices.
UQ discovery could reduce chemo side effects
23 March, 2021University of Queensland pain researchers have made a discovery that could let future cancer patients avoid chemotherapy's worst and most debilitating side effects.
